Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Qiagen N.V. Common Shares
(NY:
QGEN
)
42.30
+0.57 (+1.37%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Qiagen N.V. Common Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
Bio-Rad Laboratories, Qiagen Mull Merger Of Equals
↗
October 11, 2022
Bio-Rad Laboratories Inc (NYSE: BIO) is reportedly in talks to merge with Qiagen NV (NYSE: QGEN), but any agreement isn't likely for another few weeks or more, or it may not happen at all.
Via
Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
↗
September 27, 2022
Via
Benzinga
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
↗
September 23, 2022
The World Health Organization (WHO) warned that it struggles to identify and
Via
Benzinga
QIAGEN Launches Syndromic Test For QIAstat-Dx For Six Pathogens Similar To Monkeypox
↗
August 16, 2022
Via
Benzinga
Natera Clocks 28% Jump In Q1 Sales, Lifts FY22 Guidance
↗
May 06, 2022
Via
Benzinga
Qiagen Posts Upbeat Q1 Earnings, Raises FY22 Outlook
↗
April 27, 2022
Via
Benzinga
IGI Inex Holding (UK) Becomes Strategic Investor in Quantumrock, Cementing Partnership Between Leading Global Investment Group and AI Asset Tech Frontrunners
September 16, 2022
Via
ACCESSWIRE
QIAGEN Adds New Assays With CE-IVD Certification for NeuMoDx Integrated PCR System
September 15, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug
September 14, 2022
From
QIAGEN N.V.
Via
Business Wire
No More Free COVID-19 At-Home Tests, Federal Government Says
↗
August 29, 2022
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au
Via
Benzinga
QIAGEN Issues 2021 Sustainability Report
August 18, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Launches Syndromic Test for QIAstat-Dx Device to Combat Global Monkeypox Health Emergency
August 15, 2022
From
QIAGEN N.V.
Via
Business Wire
Qiagen Posts Robust Q2 Non-COVID Sales Growth, Lifts Annual Guidance
↗
July 27, 2022
Qiagen N.V. (NYSE: QGEN) clocked Q2 FY22 revenues of $516 million, down 9% Y/Y, well above the consensus of $488.73 million.
Via
Benzinga
QIAGEN adds new biopharma products to QIAcuity digital PCR portfolio and launches Expert Custom Assay Design Service
July 27, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN beats outlook for Q2 2022 and raises full-year 2022 outlook
July 26, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN’s Clinical Decision Support Platform QCI Surpasses Three Million NGS Patient Test Cases
July 19, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN N.V. to Release Results for Q2 2022 and Hold Webcast
July 07, 2022
From
QIAGEN N.V.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
June 21, 2022
Good morning, investor! We're back with a breakdown of the biggest pre-market stock movers for Tuesday to get the day started!
Via
InvestorPlace
U.S. CDC Endorses the Use of Digital PCR Technology for Wastewater Surveillance of Infectious Diseases – Including COVID-19 Outbreaks
June 01, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN’s Eco-Friendlier Products Earn Prestigious ACT Label
May 19, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels
May 16, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A.
May 11, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Proposes Expansion of Supervisory Board
May 11, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Adds HSV1/2 Herpes Assay With CE-IVD Certification for Use on NeuMoDx Integrated PCR System
May 05, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN exceeds outlook for Q1 2022, delivers strong 14% CER sales growth from non-COVID products and increases full-year outlook
April 26, 2022
From
QIAGEN N.V.
Via
Business Wire
Earnings Scheduled For April 27, 2022
↗
April 27, 2022
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.
Via
Benzinga
QIAGEN N.V. to release results for Q1 2022 and hold Webcast
April 20, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Reaches Milestone With 100 Million QuantiFERON Tests Used to Detect TB
March 24, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Announces 20-F Annual Report Filing for 2021 Results
March 14, 2022
From
QIAGEN N.V.
Via
Business Wire
Death Cross Looms Over Qiagen Investors
↗
February 17, 2022
If history is any guide, there may be trouble ahead for shares of Qiagen (NYSE:QGEN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
